Myomo, Inc. (MYO) Stock Analysis & Investment Frameworks
Myomo, Inc. (MYO) stock analysis on Invetso. Review Myomo, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Myomo, Inc. Company Overview
- Exchange: New York Stock Exchange Arca
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Myomo, Inc. Key Financial Metrics
- Market Cap: $47.93M
- Revenue: $40.93M
- ROE: -142.02%
- ROIC: -45.17%
- Dividend Yield: N/A
About Myomo, Inc.
Myomo, Inc. is a medical technology company specializing in wearable robotics. The company engineers and manufactures advanced myoelectric orthoses, primarily for individuals in the United States who experience neuromuscular impairments. Its flagship product, MyoPro, is an upper-limb brace that utilizes muscle signals to assist patients with weak or paralyzed arms, thereby enhancing their ability to perform daily activities. These devices aim to restore function for both adult and adolescent patients suffering from various neurological conditions, including stroke, spinal cord injury, traumatic brain injury, and brachial plexus injuries. Myomo distributes its innovative solutions through a network that includes orthotics and prosthetics providers, rehabilitation hospitals, the Veterans Health Administration, and additional distributors. Established in 2004, Myomo, Inc. maintains its corporate headquarters in Boston, Massachusetts.
Myomo, Inc. Investment Frameworks
Invetso analyzes Myomo, Inc. (MYO) across the following frameworks:
- Myomo, Inc. 10Y Growth Potential
- Myomo, Inc. Scenario Analysis
- Myomo, Inc. Risks & Opportunities
- Myomo, Inc. Economic Moat
- Myomo, Inc. Business Model
- Myomo, Inc. Management
- Myomo, Inc. SWOT Analysis
- Myomo, Inc. Porter's 5 Forces
- Myomo, Inc. PESTLE Analysis
- Myomo, Inc. ESG Analysis